• Markets
    • icon
  • Companies
AVR · ASX

Anteris Technologies Ltd. (ASX:AVR)

AU$19.5

 0.0 (0.0%)
ASX:Live
08/12/2023 04:10:08 PM
HALO Ords HALO Balance Sheet GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AVR Overview

AVR Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About AVR

Website

N/A

Telephone

61.7.3152.3200

Address

Suite 302, Level 3 9 Sherwood Road Toowong Tower Toowong, Queensland (QLD) 4066

Description

Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. It manufactures, distributes, and sells ADAPT & DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.

AVR Price Chart

Key Stats

Market Cap

AU$341.21M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 18.05 - 26.99

Trade Value (12mth)

AU$68,540.00

1 week

-2.99%

1 month

-2.74%

YTD

-9.93%

1 year

-15.22%

All time high

186.884

Key Fundamentals

EPS 3 yr Growth

236.500%

EBITDA Margin

-994.40%

Operating Cashflow

-$39m

Free Cash Flow Return

-272.30%

ROIC

-309.70%

Interest Coverage

-47.20

Quick Ratio

2.30

Other Data

Shares on Issue (Fully Dilluted)

15m

HALO Sector

Industrials

Next Company Report Date

29-Feb-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AVR Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 May 23

DurAVR Maintains Exceptional Results in New Patient Cohort

×

DurAVR Maintains Exceptional Results in New Patient Cohort

31 May 23

Ceasing to be a substantial holder from MS

×

Ceasing to be a substantial holder from MS

31 May 22

Successful Completion of Second First-In-Human Study

×

Successful Completion of Second First-In-Human Study

31 March 22

Notice of AGM and Director Nominations

×

Notice of AGM and Director Nominations

31 July 23

DurAVR first successful implantation Valve-in-Valve

×

DurAVR first successful implantation Valve-in-Valve

31 January 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 May 23

Becoming a substantial holder from MS

×

Becoming a substantial holder from MS

30 May 23

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

30 May 23

Becoming a substantial holder from MUFG

×

Becoming a substantial holder from MUFG

30 March 22

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

30 March 22

Cleansing Notice

×

Cleansing Notice

30 June 22

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

30 June 22

Notification regarding unquoted securities - AVR

×

Notification regarding unquoted securities - AVR

30 August 22

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

30 August 22

Cleansing Notice

×

Cleansing Notice

29 September 23

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

29 September 23

Cleansing Notice

×

Cleansing Notice

29 May 23

Notice of Annual General Meeting Withdrawal of Resolutions

×

Notice of Annual General Meeting Withdrawal of Resolutions

29 May 23

AGM Chairman Address and CEO Presentation

×

AGM Chairman Address and CEO Presentation

29 May 23

Results of Annual General Meeting

×

Results of Annual General Meeting

29 March 22

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

29 June 23

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

29 June 23

Cleansing Notice

×

Cleansing Notice

29 December 21

Exercise of Underwritten Listed Options

×

Exercise of Underwritten Listed Options

29 December 21

Appendix 2A

×

Appendix 2A

29 December 21

Appendix 3G

×

Appendix 3G

29 December 21

Cleansing Notice

×

Cleansing Notice

AVR Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -2.58 -3.09 -3.32 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -2.58 -3.09 -3.32 Lock Lock Lock
     Growth % Lock Lock Lock Lock -162.0 -19.6 -7.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 1.5 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 0.0 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -3.28 -1.81 -2.81 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -2.48 -2.64 -3.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.5 44.7 -54.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -66.1 -20.4 -13.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 0.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.39 1.29 0.95 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.16 1.19 0.89 Lock Lock Lock
     Growth % Lock Lock Lock Lock -93.2 647.9 -25.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 6 7 13 Lock Lock Lock
Basic m Lock Lock Lock Lock 6 7 13 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 7 8 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -58.5 10.1 -41.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 11 14 26 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -8 -9 -22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 41.0 -7.5 -144.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -115.9 -113.1 -470.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 216 213 570 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -18 -22 -46 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.3 -21.9 -110.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -251.0 -277.9 -994.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -19 -23 -47 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.2 -21.2 -106.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -268.1 -295.3 -1,032.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -17 -24 -46 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -15 -23 -44 Lock Lock Lock
     Growth % Lock Lock Lock Lock -162.5 -50.0 -93.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -215.8 -294.0 -966.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -14 -19 -39 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 1 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 8 -1 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 2 37 31 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -15 -20 -41 Lock Lock Lock
     Growth % Lock Lock Lock Lock 36.1 -33.5 -110.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.1 -2.5 -9.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 4 21 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 13 29 23 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -16 -12 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 10 15 10 Lock Lock Lock
Equity $m Lock Lock Lock Lock 2 14 13 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3 15 14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -80.6 356.3 -6.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -120.7 -77.7 -188.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -634.5 -159.7 -335.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -155.9 -175.2 -273.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -153.2 -254.4 -309.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -144.2 -208.9 -272.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -30.9 -14.4 -47.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.0 0.7 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -23.7 -108.5 -93.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.0 2.0 2.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.9 1.9 2.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 53.8 82.4 76.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -183.3 -145.3 -517.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.3 3.7 1.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 12.2 22.9 40.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 27.9 0.6 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.7 39.4 55.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.3 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.3 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -246.2 -311.7 -996.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -137.8 -82.4 -194.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -120.7 -77.7 -188.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 5.3 2.1 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -634.5 -159.7 -335.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -634.5 -159.7 -335.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 29.9 16.0 8.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 109.6 97.7 191.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 139.5 113.6 200.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 24.2 41.9 39.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 115.3 71.7 161.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVR Shortsell

Frequently Asked Questions

The current share price of Anteris Technologies Ltd. (AVR:ASX) is AU$19.5.
The 52-week high share price for Anteris Technologies Ltd. (AVR:ASX) is AU$26.99.
The 52-week low share price for Anteris Technologies Ltd. (AVR:ASX)? is AU$18.05.
Anteris Technologies Ltd. (AVR:ASX) does not pay a dividend.
Anteris Technologies Ltd. (AVR:ASX) does not pay a dividend.
Anteris Technologies Ltd. (AVR:ASX) has a franking level of 0%.
Anteris Technologies Ltd. (AVR:ASX) is classified in the Industrials.
The current P/E ratio for Anteris Technologies Ltd. (AVR:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.